High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed

NCT06972602 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Eye & ENT Hospital of Fudan University